These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 24402423)

  • 1. Validated or not validated? That is the question.
    Bartlett JM; Pritchard KI; Spears M
    J Natl Cancer Inst; 2014 Jan; 106(1):djt360. PubMed ID: 24402423
    [No Abstract]   [Full Text] [Related]  

  • 2. MicroRNA regulation of RAD51 in serous ovarian cancer modulates chemotherapy response.
    Wiemer EA; Berns EM
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25995443
    [No Abstract]   [Full Text] [Related]  

  • 3. Valproic acid alters chromatin structure by regulation of chromatin modulation proteins.
    Marchion DC; Bicaku E; Daud AI; Sullivan DM; Munster PN
    Cancer Res; 2005 May; 65(9):3815-22. PubMed ID: 15867379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding adjuvant chemotherapy for breast cancer.
    Goldhirsch A; Gelber RD
    N Engl J Med; 1994 May; 330(18):1308-9. PubMed ID: 7908411
    [No Abstract]   [Full Text] [Related]  

  • 5. Dual HER2 Targeting with Trastuzumab and Liposomal-Encapsulated Doxorubicin (MM-302) Demonstrates Synergistic Antitumor Activity in Breast and Gastric Cancer.
    Espelin CW; Leonard SC; Geretti E; Wickham TJ; Hendriks BS
    Cancer Res; 2016 Mar; 76(6):1517-27. PubMed ID: 26759238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of multikinase inhibitors on caspase-independent cell death and DNA damage in HER2-overexpressing breast cancer cells.
    Seoane S; Montero JC; Ocaña A; Pandiella A
    J Natl Cancer Inst; 2010 Sep; 102(18):1432-46. PubMed ID: 20811002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of interferon on 5-fluorouracil-induced perturbations in pools of deoxynucleotide triphosphates and DNA strand breaks.
    Wadler S; Horowitz R; Mao X; Schwartz EL
    Cancer Chemother Pharmacol; 1996; 38(6):529-35. PubMed ID: 8823494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the human apurinic/apyrimidinic endonuclease (APE1) repair activity and sensitization of breast cancer cells to DNA alkylating agents with lucanthone.
    Luo M; Kelley MR
    Anticancer Res; 2004; 24(4):2127-34. PubMed ID: 15330152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The beautiful history of pertuzumab.
    Perez-Garcia J; Muñoz-Couselo E; Ortega V; Cortes J
    Expert Rev Anticancer Ther; 2012 Jun; 12(6):703-5. PubMed ID: 22716485
    [No Abstract]   [Full Text] [Related]  

  • 10. A Boolean network model of the FA/BRCA pathway.
    Rodríguez A; Sosa D; Torres L; Molina B; Frías S; Mendoza L
    Bioinformatics; 2012 Mar; 28(6):858-66. PubMed ID: 22267503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can trastuzumab be effective against tumors with low HER2/Neu (ErbB2) receptors?
    Arteaga CL
    J Clin Oncol; 2006 Aug; 24(23):3722-5. PubMed ID: 16847283
    [No Abstract]   [Full Text] [Related]  

  • 12. Tamoxifen, uridine transport, and dome formation in human breast cancer cells.
    Allegra CJ
    Cancer J Sci Am; 1995; 1(3):182-3. PubMed ID: 9166472
    [No Abstract]   [Full Text] [Related]  

  • 13. Acquisition of Relative Interstrand Crosslinker Resistance and PARP Inhibitor Sensitivity in Fanconi Anemia Head and Neck Cancers.
    Lombardi AJ; Hoskins EE; Foglesong GD; Wikenheiser-Brokamp KA; Wiesmüller L; Hanenberg H; Andreassen PR; Jacobs AJ; Olson SB; Keeble WW; Hays LE; Wells SI
    Clin Cancer Res; 2015 Apr; 21(8):1962-72. PubMed ID: 25609062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactive oxygen species-mediated synergistic and preferential induction of cell death and reduction of clonogenic resistance in breast cancer cells by combined cisplatin and FK228.
    Pluchino LA; Choudhary S; Wang HC
    Cancer Lett; 2016 Oct; 381(1):124-32. PubMed ID: 27477899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergy of irofulven in combination with other DNA damaging agents: synergistic interaction with altretamine, alkylating, and platinum-derived agents in the MV522 lung tumor model.
    Kelner MJ; McMorris TC; Rojas RJ; Estes LA; Suthipinijtham P
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):19-26. PubMed ID: 18305940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthracycline war: no victor yet.
    Young P
    J Natl Cancer Inst; 2009 Sep; 101(17):1171-3. PubMed ID: 19706625
    [No Abstract]   [Full Text] [Related]  

  • 18. Bleomycin-induced chromosome damage in lymphocytes indicates inefficient DNA repair capacity in breast cancer families.
    Roy SK; Trivedi AH; Bakshi SR; Patel SJ; Shukla PH; Bhatavdekar JM; Patel DD; Shah PM
    J Exp Clin Cancer Res; 2000 Jun; 19(2):169-73. PubMed ID: 10965814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A major switch for the Fanconi anemia DNA damage-response pathway.
    Wang W
    Nat Struct Mol Biol; 2008 Nov; 15(11):1128-30. PubMed ID: 18985065
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of vitamins C and E on antioxidant status of breast-cancer patients undergoing chemotherapy.
    Suhail N; Bilal N; Khan HY; Hasan S; Sharma S; Khan F; Mansoor T; Banu N
    J Clin Pharm Ther; 2012 Feb; 37(1):22-6. PubMed ID: 21204889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.